Rockefeller Capital Management
CLPT icon

Rockefeller Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Rockefeller Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1K Hold
1,800
– – ﹤0.01% 3559
2026
Q1 		$16.4K Buy
1,800
+300
+20% +$3.79K ﹤0.01% 3790
2025
Q4 		$20.5K Buy
1,500
+170
+13% +$3.15K ﹤0.01% 3507
2025
Q3 		$29K Buy
+1,330
New +$15.7K ﹤0.01% 3171

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Rockefeller Capital Management's CLPT Position: Q2 2026 in Review

Rockefeller Capital Management held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 1,800 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3559.

Rockefeller Capital Management first reported a position in CLPT in Q3 2025 and has held it in 4 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Rockefeller Capital Management held 1,800 shares of ClearPoint Neuro worth $32.1K as of Q2 2026.
  • Rockefeller Capital Management left its ClearPoint Neuro share count unchanged in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3559 holding.
  • Rockefeller Capital Management first reported a position in ClearPoint Neuro in Q3 2025 and has held it in 4 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.